A pilot study, performed at the University of Portsmouth, has shown that a drug commonly used to thin blood, heparin, may offer a significant improvement in symptoms of chronic obstructive pulmonary disease (COPD). more

4 Dec 2017 14:09 News

This year's CPhI Worldwide has proved a great success for Pharma Action, which presented its strategy to become one of Europe's leading producers of heparin — completely produced under GMP-standards and already fully compliant with the latest FDA... more

23 Oct 2013 16:21 News